SAN DIEGO—BioMed Realty Trust is in the midst of a realignment that will include a number of promotions and additions to its leadership team.

The company announced Wednesday that, effective immediately, president and COO Kent Griffin is leaving BioMed to pursue other business opportunities. During his nine-year career with firm, Griffin served as chief financial officer before taking on his most recent position. As a result of Griffin's departure, the company expects to record a severance charge of $0.05 per diluted share in the first quarter of 2015.

The company's executive bench is strengthened with the promotion of John Bonanno to EVP of leasing and development and Jon Klassen to EVP and general counsel. The two, along with Jim Berens, president of Wexford Science and Technology, will join the executive leadership team made up of Alan Gold, co-founder, chairman and CEO, Gary Kreitzer, co-founder and EVP, Greg Lubushkin, CFO, and Karen Sztraicher, EVP of asset management.

“With our deep bench of high quality leaders, I have never been more excited about our company and our opportunity to provide unique real estate solutions at the intersection of the growing health care industry and innovation sector,” said Gold. “On a personal level, Kent will be missed and I want to thank him for his valuable contributions over his nine-year career at BioMed Realty.”

BioMed Realty has grown from a real estate start-up to become the leading provider of real estate to the life science industry with 18 million rentable square feet and more than $7 billion in total gross assets in just ten years.

Instant Insights /

Leadership Realigned at BioMed Realty

Related Stories

Recommended For You